[Drug therapy of parkinsonism].
D000547:Amantadine / Q000627:therapeutic use; D001971:Bromocriptine / Q000627:therapeutic use; D018492:Dopamine Antagonists; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use; D018377:Neurotransmitter Agents / Q000502:physiology; D010276:Parasympatholytics / Q000494:pharmacology / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology
D018492:Dopamine Antagonists; D018377:Neurotransmitter Agents; D010276:Parasympatholytics; D001971:Bromocriptine; D007980:Levodopa; D000547:Amantadine
Parkinsonismin Lääkehoito.